Kurt Graves's Net Worth
$33.1 Million
Who is Kurt Graves?
Kurt Graves has an estimated net worth of $33.1 Million. This is based on reported shares across multiple companies, which include VERTEX PHARMACEUTICALS INC / MA, Seres Therapeutics, Inc., Radius Health, Inc., Pulmatrix, Inc., and ACHILLION PHARMACEUTICALS INC.
SEC CIK
Kurt Graves's CIK is 0001406337
Past Insider Trading and Trends
2015 was Kurt Graves's most active year for acquiring shares with 11 total transactions. Kurt Graves's most active month to acquire stocks was the month of January. 2008 was Kurt Graves's most active year for disposing of shares, totalling 22 transactions. Kurt Graves's most active month to dispose stocks was the month of April. 2011 saw Kurt Graves paying a total of $826,464.52 for 256,666 shares, this is the most they've acquired in one year. In 2015 Kurt Graves cashed out on 100,000 shares for a total of $4,863,157.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
VERTEX PHARMACEUTICALS INC / MA (VRTX) Snapshot price: $468
EVP, Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.44% | -1.50K |
$34.70 | -$52,050.00 | 59.88K |
Scheduled
|
Oct 19
| ||
Form 4
| -5.93% | -3.87K |
$33.47 | -$129,461.96 | 61.38K |
Scheduled
|
Jul 20
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 16
| |||
Form 4
| -1.40% | -925.00 |
$28.44 | -$26,307.00 | 65.25K |
Scheduled
|
May 18
| ||
Form 4
| -3.70% | -2.51K |
$32.00 | -$80,224.00 | 65.25K |
Scheduled
|
Apr 28
| ||
Form 4
| -0.72% | -493.00 |
$26.98 | -$13,303.16 | 67.75K |
Scheduled
|
Apr 21
| ||
Form 4
| +21.52% | 12.08K |
$0.01 | $120.84 | 68.25K |
Feb 5
| |||
Form 4
| -0.67% | -379.00 |
$26.10 | -$9,891.90 | 56.16K |
Scheduled
|
Nov 18
| ||
Form 4
| -0.86% | -485.00 |
$25.65 | -$12,440.25 | 56.16K |
Scheduled
|
Oct 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
| -4.91% | -2.92K |
$32.54 | -$95,184.75 | 56.65K |
Scheduled
|
Jul 21
| ||
Form 4
| -5.62% | -3.55K |
$31.05 | -$110,196.45 | 59.57K |
Scheduled
|
Jun 5
| ||
Form 4
| -2.34% | -1.51K |
$27.59 | -$41,717.53 | 63.12K |
Scheduled
|
May 20
| ||
Form 4
| -1.48% | -951.00 |
$27.32 | -$25,983.58 | 63.12K |
Scheduled
|
May 13
| ||
Form 4
| +23.24% | 12.08K |
$0.01 | $120.84 | 64.07K |
Feb 7
| |||
Form 4
| +8.31% | 3.99K |
$25.15 | $100,342.90 | 51.99K |
Nov 6
| |||
Form 4
|
∞
| 48K |
$0.01 | $480.00 | 48K |
Jul 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Seres Therapeutics, Inc. (MCRB) Snapshot price: $1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Radius Health, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +100.00% | 5.5K |
—
|
—
| 11K |
Feb 20
| |||
Form 4
| -46.60% | -4.80K |
$22.32 | -$107,136.00 | 5.5K |
Scheduled
|
Apr 16
| ||
Form 4
| +114.58% | 5.5K |
—
|
—
| 10.3K |
Feb 22
| |||
Form 4
|
∞
| 4.8K |
—
|
—
| 4.8K |
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
—
|
0
|
$38.67 | -$1,422,006.04 |
0
|
Scheduled
|
Aug 17
| ||
Form 4
|
—
|
0
|
$38.67 | -$144,493.96 |
0
|
Scheduled
|
Aug 10
| ||
Form 4
|
—
|
0
|
$38.41 | -$1,553,407.50 |
0
|
Scheduled
|
Jul 6
| ||
Form 4
|
—
|
0
|
$31.20 | -$1,192,750.00 |
0
|
Scheduled
|
Jun 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pulmatrix, Inc. (PULM) Snapshot price: $2.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15 - Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACHILLION PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -22.71K |
$6.30 | -$143,066.70 |
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||